简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2026-07-10 10:19 First Randomized Controlled Trial Shows Promise of a Ketogenic Diet in Psychotic Disorders
2026-07-09 09:51 Merck Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients With Active Skin Manifestations
2026-07-08 15:29 Biocytogen and Whitehawk Therapeutics Enter Global Collaboration for Bispecific Antibody ADC Development
2026-07-08 10:39 Morinaga Milk Achieves Self-Affirmed GRAS Status for LAC-Living+™, Expanding U.S. Opportunities for Its Postbiotic Ingredient
2026-07-07 15:44 Agenus Reports Landmark BOT+BAL Data Showing 33% Three-Year Overall Survival in Refractory MSS Metastatic Colorectal Cancer Without Active Liver Metastases at ESMO GI 2026
2026-07-07 15:27 Orion and Shilpa Medicare Expand Partnership to Develop and Supply Nivolumab Biosimilar for Europe
2026-07-07 14:23 Landmark Global Galderma Survey Shows 9 out of 10 People Are Affected by Skin Quality Concerns
2026-07-03 10:44 Brenus Pharma Strengthens Its Governance With Designation of a New President and Appointment of Former Novo Nordisk EVP as Independent Member
2026-07-02 15:29 Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution
2026-07-01 14:34 Shoko Co., Ltd. Began Commercial Production of Pharmaceutical Excipient “Viscomedi” at Its South Korean Plant
2026-07-01 14:26 BeOne Medicines Announces Positive Phase 3 Results for BRUKINSA in Frontline Mantle Cell Lymphoma
2026-07-01 13:13 Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States
2026-07-01 11:04 Hengrui’s Heng Yi® Approved in China as an Innovative Cyclosporine Ophthalmic Solution for the Treatment of Dry Eye Disease
2026-07-01 10:54 Medisca Enters Its Next Chapter Under Founder Antonio Dos Santos
2026-06-30 14:03 Court Clears Biocytogen’s RenNano® in Landmark Patent Dispute Against Harbour
2026-06-30 11:19 Cartilage Tissue Engineering Heads to Orbit in NSF and NASA-supported Study at the International Space Station
2026-06-30 11:02 Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)
2026-06-29 13:43 Amazfit Brings Interactive iOS Notifications to Select Smartwatches in Europe
2026-06-29 13:15 Burjeel Holdings Prices First MENA Healthcare Sukuk Since 2018, 3.2x Oversubscribed
2026-06-29 13:10 DAYBU® (trofinetide) Recommended for Approval in the European Union by CHMP